Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2
1.0.0-ballot - STU Ballot International flag

This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0-ballot: STU 1 Ballot 3) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

: valueset-rimexolone - XML Representation

Draft as of 2018-07-02

Raw xml | Download



<ValueSet xmlns="http://hl7.org/fhir">
  <id value="valueset-rimexolone"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>220785</td><td>Vexol</td></tr><tr><td>55681</td><td>rimexolone</td></tr><tr><td>207446</td><td>rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]</td></tr><tr><td>568209</td><td>rimexolone 10 MG/ML [Vexol]</td></tr><tr><td>365826</td><td>rimexolone Ophthalmic Suspension [Vexol]</td></tr><tr><td>199115</td><td>rimexolone 10 MG/ML Ophthalmic Suspension</td></tr><tr><td>328510</td><td>rimexolone 10 MG/ML</td></tr><tr><td>379299</td><td>rimexolone Ophthalmic Suspension</td></tr><tr><td>1157440</td><td>rimexolone Ophthalmic Product</td></tr><tr><td>1188083</td><td>Vexol Ophthalmic Product</td></tr></table></li></ul></div>
  </text>
  <url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone"/>
  <version value="1.0.0-ballot"/>
  <name value="Valueset_rimexolone"/>
  <title value="Rimexolone Medications Value Set"/>
  <status value="draft"/>
  <experimental value="true"/>
  <date value="2018-07-02"/>
  <publisher value="HL7 Clinical Decision Support Workgroup"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/Special/committees/dss"/>
    </telecom>
  </contact>
  <description value="ValueSet containing drug identifiers for rimexolone."/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <copyright value="(copyright expectations unknown)"/>
  <compose>
    <include>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <concept>
        <code value="220785"/>
        <display value="Vexol"/>
      </concept>
      <concept>
        <code value="55681"/>
        <display value="rimexolone"/>
      </concept>
      <concept>
        <code value="207446"/>
        <display value="rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]"/>
      </concept>
      <concept>
        <code value="568209"/>
        <display value="rimexolone 10 MG/ML [Vexol]"/>
      </concept>
      <concept>
        <code value="365826"/>
        <display value="rimexolone Ophthalmic Suspension [Vexol]"/>
      </concept>
      <concept>
        <code value="199115"/>
        <display value="rimexolone 10 MG/ML Ophthalmic Suspension"/>
      </concept>
      <concept>
        <code value="328510"/>
        <display value="rimexolone 10 MG/ML"/>
      </concept>
      <concept>
        <code value="379299"/>
        <display value="rimexolone Ophthalmic Suspension"/>
      </concept>
      <concept>
        <code value="1157440"/>
        <display value="rimexolone Ophthalmic Product"/>
      </concept>
      <concept>
        <code value="1188083"/>
        <display value="Vexol Ophthalmic Product"/>
      </concept>
    </include>
  </compose>
</ValueSet>